• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ROCHE DIAGNOSTICS COBAS ELECSYS ANTI-TPO; SYSTEM, TEST, THYROID AUTOANTIBODY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ROCHE DIAGNOSTICS COBAS ELECSYS ANTI-TPO; SYSTEM, TEST, THYROID AUTOANTIBODY Back to Search Results
Catalog Number 06368590190
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/01/2019
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).
 
Event Description
The initial reporter complained of discrepant results for 2 patient samples tested for elecsys ft4 iii (ft4 iii), elecsys tsh (tsh) and elecsys anti-tpo (anti-tpo) on a cobas e801 module compared to the abbott architect method.This medwatch will cover anti-tpo.Refer to medwatch with patient identifier (b)(6) for information on the ft4 iii results and medwatch with patient identifier (b)(6) for information on the tsh results.The results from the e801 module were reported outside of the laboratory.The customer doesn't think the roche results are correct as they don't correspond to the patients' medical history or clinical picture.There was no allegation that an adverse event occurred.The e801 module serial number was (b)(4).The customer suspects an interference in the patient samples affecting the results.
 
Manufacturer Narrative
Two (2) samples of 2 different patients were investigated.Investigation of sample 1 confirmed an interferent against a component of the reagent which is consistent with falsely increased values of the anti-tpo assay.This interference is covered in product labeling: in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings.During investigation of sample 2 no interferring factors were found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROCHE DIAGNOSTICS COBAS ELECSYS ANTI-TPO
Type of Device
SYSTEM, TEST, THYROID AUTOANTIBODY
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key8611212
MDR Text Key145101504
Report Number1823260-2019-01812
Device Sequence Number1
Product Code JZO
Combination Product (y/n)N
PMA/PMN Number
K051890
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 07/25/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/15/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number06368590190
Device Lot Number36832100
Was Device Available for Evaluation? Yes
Date Manufacturer Received04/24/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age78 YR
-
-